Kestra Advisory Services LLC Purchases 1,185,120 Shares of Axon Enterprise, Inc $AXON

Key Points

• Kestra Advisory Services sharply increased its Axon stake, buying 1,185,120 shares in Q3 to bring its holdings to 1,188,963 shares, valued at about $502 million.
• Axon’s Q3 revenue rose 27.8% year over year to about $909 million, but revenue and EPS of $1.72 both fell short of analyst estimates. Its shares were reported down 9.8%.
• Analysts’ consensus rating was Moderate Buy, with an average price target of $688.38; the article also reports insider sales totaling 37,397 shares over 90 days.

Kestra Advisory Services LLC raised its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 30,838.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,188,963 shares of the biotechnology company's stock after buying an additional 1,185,120 shares during the period. Axon Enterprise comprises approximately 1.4% of Kestra Advisory Services LLC's investment portfolio, making the stock its 7th biggest position. Kestra Advisory Services LLC owned approximately 1.46% of Axon Enterprise worth $502,361,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. State Street Corp lifted its position in shares of Axon Enterprise by 5,700.2% in the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock worth $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in shares of Axon Enterprise by 18,050.2% during the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock worth $7,400,094,000 after purchasing an additional 13,127,348 shares during the period. Robeco Institutional Asset Management B.V. grew its position in Axon Enterprise by 391,214.9% during the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock valued at $2,952,943,000 after purchasing an additional 6,987,098 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Axon Enterprise by 5,022.8% during the third quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company's stock valued at $1,802,719,000 after purchasing an additional 4,183,302 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in Axon Enterprise by 8,432.6% during the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company's stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey Kunins sold 9,605 shares of the firm's stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This trade represents a 8.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company's stock, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 37,397 shares of company stock worth $21,234,034. Company insiders own 4.20% of the company's stock.

Axon Enterprise Trading Down 9.8%

NASDAQ:AXON opened at $382.56 on Friday. The stock's 50 day moving average price is $447.49 and its 200 day moving average price is $476.73. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $665.07. The company has a market capitalization of $31.08 billion, a P/E ratio of 158.74, a P/E/G ratio of 8.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). The business had revenue of $908.55 million during the quarter, compared to analyst estimates of $934.33 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. Axon Enterprise's revenue was up 27.8% compared to the same quarter last year. During the same quarter last year, the firm earned $1.17 earnings per share. On average, research analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on AXON. Argus lifted their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the company a "buy" rating in a research note on Thursday, September 3rd. Raymond James Financial set a $675.00 price target on shares of Axon Enterprise in a report on Thursday, October 15th. Citigroup reaffirmed a "market outperform" rating on shares of Axon Enterprise in a research note on Monday. Zacks Research lowered Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday. Finally, Morgan Stanley lifted their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus price target of $688.38.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.